(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 13.41% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.71%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Astrana Health's revenue in 2025 is $2,250,574,000.On average, 2 Wall Street analysts forecast ASTH's revenue for 2025 to be $146,063,184,445, with the lowest ASTH revenue forecast at $145,474,536,469, and the highest ASTH revenue forecast at $146,651,832,421. On average, 3 Wall Street analysts forecast ASTH's revenue for 2026 to be $158,905,577,183, with the lowest ASTH revenue forecast at $145,143,772,368, and the highest ASTH revenue forecast at $167,379,529,199.
In 2027, ASTH is forecast to generate $190,778,005,936 in revenue, with the lowest revenue forecast at $190,778,005,936 and the highest revenue forecast at $190,778,005,936.